La Jolla, CA, United States of America

Sheldon S Hendler

This inventor holds 17 USPTO granted patents and 3 published patent applications, primarily in Antiviral Agents. Top assignees: Vyrex Corporation, Biodor U.S. Holding, Pcb Associates, Inc.. Active years: 1991-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheldon S Hendler. Retrieved from https://idiyas.com/inventor/sheldon-s-hendler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 94.1

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 249(Granted Patents)


Company Filing History:


Years Active: 1991-2014

Loading Chart...
Areas of Expertise:
NADPH Oxidase
Isoflavone Derivatives
Prodrugs
Antiviral Agents
Metallic Oligopeptides
Urushiols
Delivery Formulation
Oxidative Damage
Skin Delipidation
Cerumen Removal
Tocopherol
Viral Infections
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sheldon S. Hendler

Introduction

Sheldon S. Hendler is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of medical and nutritional science, holding a total of 17 patents. His work focuses on innovative compositions that have potential therapeutic applications.

Latest Patents

One of his latest patents involves compositions for inhibiting NADPH oxidase activity. Phycobilins are disclosed to have prodrug activity as inhibitors of NADPH oxidase activity and are useful in the prophylaxis and/or treatment of medical conditions associated with or linked to NADPH oxidase activity. Compositions containing phycobilins are described which facilitate the administration of these compounds. Another notable patent pertains to isoflavone derivatives. Isoflavones are modified by esterification at one or more of the C4', C5, C6, and C7 positions to promote bioavailability, especially to enhance solubility over the corresponding unesterified isoflavones. Preferred modifications produce a carboxylic acid hemiester or a phosphate ester which is biologically hydrolysable. These esterified isoflavones may be employed therapeutically or prophylactically for a variety of conditions, provided as dietary supplements, or added to natural or processed foodstuffs.

Career Highlights

Throughout his career, Sheldon has worked with various companies, including Vyrex Corporation. His innovative work has led to advancements in the fields of health and nutrition, showcasing his commitment to improving human health through scientific research.

Collaborations

Sheldon has collaborated with notable individuals in his field, including Robert A. Sanchez and Jan Zielinski. These collaborations have contributed to the development of his innovative ideas and patents.

Conclusion

Sheldon S. Hendler's contributions to science and innovation are noteworthy, particularly in the areas of medical and nutritional advancements. His patents reflect a dedication to improving health outcomes through innovative compositions and formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…